Published in Nephrol Dial Transplant on December 01, 2003
Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Med Sci Monit (2011) 0.93
The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients. Adv Biomed Res (2014) 0.77
Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy. Int J Mol Sci (2013) 0.75
Orosomucoid is an independent predictor of prognosis in chronic heart failure. Wien Klin Wochenschr (2016) 0.75
Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC). BJU Int (2013) 2.10
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
ERG rearrangement in small cell prostatic and lung cancer. Histopathology (2010) 1.64
Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension. Hypertension (2006) 1.53
Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford) (2009) 1.52
The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol Dial Transplant (2004) 1.51
Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis (2010) 1.43
Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients. Ren Fail (2006) 1.43
SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum Pathol (2011) 1.40
Type III secretion genes in Aeromonas salmonicida subsp salmonicida are located on a large thermolabile virulence plasmid. J Clin Microbiol (2003) 1.37
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor. Mod Pathol (2010) 1.33
Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis (2006) 1.31
From DNA repair to proteome protection: new molecular insights for preventing non-melanoma skin cancers and skin aging. J Drugs Dermatol (2014) 1.13
Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. J Hypertens (2008) 1.11
Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. Clin Immunol (2003) 1.08
Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest (2007) 1.07
AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension. J Hypertens (2006) 1.07
Unusual heme-histidine bond in the active site of a chaperone. J Am Chem Soc (2005) 1.06
An experimental double-blind irradiation study of a novel topical product (TPF 50) compared to other topical products with DNA repair enzymes, antioxidants, and growth factors with sunscreens: implications for preventing skin aging and cancer. J Drugs Dermatol (2014) 1.05
Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res (2005) 1.05
Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant (2007) 1.03
Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli. J Infect Dis (2013) 1.00
Robotic totally endoscopic coronary artery bypass: a word of caution implicated by a five-year follow-up. J Thorac Cardiovasc Surg (2008) 0.97
A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients. Ann N Y Acad Sci (2007) 0.95
Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Med Sci Monit (2011) 0.93
Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats. Vascul Pharmacol (2007) 0.93
Axial coordination of heme in ferric CcmE chaperone characterized by EPR spectroscopy. Biophys J (2006) 0.92
Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease. Mov Disord (2008) 0.91
Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer. Clin Biochem (2010) 0.90
Exome enrichment and SOLiD sequencing of formalin fixed paraffin embedded (FFPE) prostate cancer tissue. Int J Mol Sci (2012) 0.88
Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis. J Neurol (2007) 0.88
The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats. Kidney Blood Press Res (2007) 0.86
Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis. Kidney Blood Press Res (2008) 0.86
Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med (2006) 0.85
Soluble cytokine receptors in renal vasculitis and lupus nephritis. Med Sci Monit (2002) 0.84
Twiddler's syndrome in an adolescent patient with ICD during neurological and physical rehabilitation. Clin Res Cardiol (2008) 0.84
Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact. Eur J Clin Pharmacol (2010) 0.84
Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course. Int J Cancer (2012) 0.84
Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats. J Hypertens (2010) 0.84
A novel method to inject hyaluronic acid: the Fern Pattern Technique. J Drugs Dermatol (2007) 0.83
No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients. Blood Purif (2006) 0.83
Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression. Hum Pathol (2012) 0.83
Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament. J Neuroimmunol (2012) 0.83
Prognostic significance of phospho-histone H3 in prostate carcinoma. World J Urol (2013) 0.83
Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer. PLoS One (2013) 0.82
MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer. Int J Cancer (2013) 0.82
Advanced glycation end-products in patients with chronic alcohol misuse. Alcohol Alcohol (2004) 0.82
Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations. Proteins (2008) 0.81
Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy. Ren Fail (2002) 0.81
Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis? Kidney Blood Press Res (2006) 0.81
Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene. Arch Physiol Biochem (2008) 0.81
Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus. Eur J Clin Pharmacol (2007) 0.81
Oxidative stress and platelet function in multiple myeloma and renal insufficiency: clinical relations of different tests. Thromb Res (2002) 0.80
Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension. Vascul Pharmacol (2009) 0.80
Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats. Vascul Pharmacol (2008) 0.80
Pathobiochemistry of nephrotic syndrome. Adv Clin Chem (2003) 0.80
Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer. Pathology (2015) 0.79
Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment. Am Heart J (2003) 0.79
Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J Perinat Med (2008) 0.79
Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clin Biochem (2009) 0.79
Antiphospholipid antibodies in patients with lupus nephritis. Ren Fail (2003) 0.79
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int Suppl (2003) 0.79
Avoidance of the cytochrome c biogenesis system by periplasmic CXXCH motifs. Biochem Soc Trans (2008) 0.79
Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation. Kidney Blood Press Res (2007) 0.78
Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes. Scand J Clin Lab Invest (2010) 0.78
ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer. Virchows Arch (2012) 0.78
Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun (2015) 0.78
Signal transduction in alcohol-related diseases. Alcohol Clin Exp Res (2005) 0.78
Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease. Blood Press Monit (2005) 0.78
RAGE polymorphisms, renal function and histological finding at 12 months after renal transplantation. Clin Biochem (2008) 0.78
Pregnancy-associated plasma protein A (PAPP-A) and preeclampsia. Adv Clin Chem (2014) 0.78
Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis. Cytokine (2012) 0.78
Resting energy expenditure and thermal balance during isothermic and thermoneutral haemodialysis--heat production does not explain increased body temperature during haemodialysis. Nephrol Dial Transplant (2007) 0.78
Advanced glycation end products in myocardial reperfusion injury. Heart Vessels (2011) 0.77
Plasma calprotectin in chronically dialyzed end-stage renal disease patients. Inflamm Res (2009) 0.77
Physiology in daily hemodialysis in terms of the time average concentration/time average deviation concept. Hemodial Int (2004) 0.77
Glyoxalase I Glu111Ala polymorphism in patients with breast cancer. Cancer Invest (2009) 0.77
Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients. Kidney Blood Press Res (2010) 0.77
Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio. Ren Fail (2003) 0.77